This company has been marked as potentially delisted and may not be actively trading. Boundless Bio (BOLD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock BOLD vs. NTRB, SAVA, OKYO, CHRS, CRBP, ELUT, ADAG, IVVD, VERU, and JSPRShould you be buying Boundless Bio stock or one of its competitors? The main competitors of Boundless Bio include Nutriband (NTRB), Cassava Sciences (SAVA), OKYO Pharma (OKYO), Coherus Oncology (CHRS), Corbus Pharmaceuticals (CRBP), Elutia (ELUT), Adagene (ADAG), Invivyd (IVVD), Veru (VERU), and Jasper Therapeutics (JSPR). These companies are all part of the "medical" sector. Boundless Bio vs. Its Competitors Nutriband Cassava Sciences OKYO Pharma Coherus Oncology Corbus Pharmaceuticals Elutia Adagene Invivyd Veru Jasper Therapeutics Boundless Bio (NASDAQ:BOLD) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Do analysts prefer BOLD or NTRB? Boundless Bio currently has a consensus price target of $4.00, suggesting a potential upside of 238.98%. Nutriband has a consensus price target of $13.00, suggesting a potential upside of 63.32%. Given Boundless Bio's higher possible upside, equities analysts clearly believe Boundless Bio is more favorable than Nutriband.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boundless Bio 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Nutriband 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of BOLD or NTRB? 19.7% of Nutriband shares are owned by institutional investors. 21.1% of Boundless Bio shares are owned by company insiders. Comparatively, 54.1% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility & risk, BOLD or NTRB? Boundless Bio has a beta of -1.34, indicating that its share price is 234% less volatile than the S&P 500. Comparatively, Nutriband has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Is BOLD or NTRB more profitable? Boundless Bio has a net margin of 0.00% compared to Nutriband's net margin of -415.93%. Boundless Bio's return on equity of -41.60% beat Nutriband's return on equity.Company Net Margins Return on Equity Return on Assets Boundless BioN/A -41.60% -34.53% Nutriband -415.93%-68.25%-60.40% Does the media favor BOLD or NTRB? In the previous week, Boundless Bio and Boundless Bio both had 1 articles in the media. Nutriband's average media sentiment score of 1.89 beat Boundless Bio's score of 0.00 indicating that Nutriband is being referred to more favorably in the news media. Company Overall Sentiment Boundless Bio Neutral Nutriband Very Positive Which has better valuation & earnings, BOLD or NTRB? Nutriband has higher revenue and earnings than Boundless Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBoundless BioN/AN/A-$65.36MN/AN/ANutriband$2.14M41.47-$10.48M-$0.90-8.84 SummaryNutriband beats Boundless Bio on 7 of the 12 factors compared between the two stocks. Get Boundless Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BOLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BOLD vs. The Competition Export to ExcelMetricBoundless BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.42M$66.29M$5.61B$9.11BDividend YieldN/AN/A5.24%4.02%P/E Ratio-0.40N/A27.9620.25Price / SalesN/AN/A430.8999.65Price / CashN/AN/A37.4658.16Price / Book0.170.958.045.49Net Income-$65.36M-$26.57M$3.18B$250.27M Boundless Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BOLDBoundless Bio2.7837 of 5 stars$1.18-48.7%$4.00+239.0%-71.9%$26.42MN/A-0.40207Gap UpNTRBNutriband3.093 of 5 stars$8.02+1.9%$13.00+62.1%+33.8%$89.42M$2.14M-8.9110SAVACassava Sciences4.1763 of 5 stars$1.85+2.2%$54.50+2,845.9%-80.6%$89.37MN/A-1.2330Positive NewsOKYOOKYO Pharma3.2237 of 5 stars$2.61+1.6%$7.00+168.2%+91.2%$88.32MN/A0.007Positive NewsCHRSCoherus Oncology3.7992 of 5 stars$0.76+4.0%$4.68+516.0%-45.3%$88.14M$266.96M-0.67330News CoverageCRBPCorbus Pharmaceuticals4.4563 of 5 stars$7.16+3.8%$50.88+610.5%-84.5%$87.64MN/A-1.7040Positive NewsELUTElutia3.5721 of 5 stars$2.13+7.6%$8.00+275.6%-47.8%$87.59M$24.38M-1.10180ADAGAdagene2.5923 of 5 stars$1.85-5.1%$8.00+332.4%-29.5%$87.15M$100K0.00260Gap UpHigh Trading VolumeIVVDInvivyd3.4526 of 5 stars$0.72+0.9%$5.85+711.1%-36.9%$86.52M$25.38M-0.60100VERUVeru2.884 of 5 stars$0.59+1.4%$4.00+578.0%-35.5%$86.48M$16.89M-2.46230Positive NewsGap UpJSPRJasper Therapeutics3.5337 of 5 stars$5.74+3.4%$59.25+932.2%-82.5%$86.22MN/A-1.1020News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Nutriband Competitors Cassava Sciences Competitors OKYO Pharma Competitors Coherus Oncology Competitors Corbus Pharmaceuticals Competitors Elutia Competitors Adagene Competitors Invivyd Competitors Veru Competitors Jasper Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BOLD) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boundless Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boundless Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BOLD Stock Alerts